TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
DOCS

Doximity Inc

Healthcare · Health Information Services

26.40$ +1.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Doximity Inc (DOCS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 42 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow DOCS
Line item Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
7.9 7.9 8.8 13 24 38 33 19 27 47 45 40 49 47 57 13 50 64 41 68 65 98 62 94 61 110 42 306
-0.4 -0.4 0.8 7.8 1.0 1.0 1.2 1.2 1.4 1.4 5.1 2.6 2.6 2.7 2.6 2.6 2.5 2.5 2.6 2.6 2.7 2.8 2.8 3.5 4.0 4.1 4.3 16
0.6 0.6 1.0 1.2 2.2 2.9 5.1 6.7 9.8 9.8 9.5 11 14 13 14 13 12 12 17 18 19 18 22 29 34 37 37 137
3.5 3.5 2.1 – 6.5 6.5 6.2 8.7 -20 3.3 11 14 26 18 14 12 – – – – – – – – – – – –
– -5.9 2.8 -1.9 2.8 6.3 -3.7 -29 -11 3.2 5.8 -5.1 -15 -7.2 9.2 -35 -14 15 -20 1.3 19 28 -17 -2.5 -40 14 8.6 -20
0.1 0.1 1.2 1.4 1.1 0.9 0.8 1.1 1.7 2.1 2.1 1.8 1.2 1.0 1.6 1.3 1.3 1.6 1.7 1.5 1.8 1.5 2.0 2.4 2.4 2.3 0.1 7.1
12 12 -15 15 -27 -43 -57 -534 -26 -24 -42 -19 13 -13 117 -50 40 -76 30 24 -59 -24 2.7 -32 38 138 113 257
– – – – – – – – 3.1 3.1 – – – – – – – – – – – – – – – – – –
– – 0.0 0.0 -0.4 -1.7 -2.7 -0.1 -0.4 -0.4 -8.9 -61 -1.1 -15 -22 -164 -77 -18 -51 -23 -19 -27 -122 -22 -197 -91 -92 -401
0.6 0.6 0.2 1.1 2.3 1.7 552 0.1 3.8 4.4 -6.0 -57 0.8 -12 -26 -161 -76 -14 -57 -20 -25 -30 -137 -30 -204 -93 -101 -427
21 21 -5.8 28 -1.0 -3.6 528 -515 5.6 28 -2.7 -36 63 22 149 -198 15 -26 15 73 -19 44 -72 32 -104 154 54 136
– 7.8 7.6 11 23 37 32 18 26 45 43 38 47 46 56 12 49 62 40 67 63 97 60 92 59 107 42 299

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?